Genetic Influences in Breast Cancer Drug Resistance

Breast cancer is the most common cancer in adult women aged 20 to 50 years. The therapeutic regimens that are commonly recommended to treat breast cancer are human epidermal growth factor receptor 2 (HER2) targeted therapy, endocrine therapy, and systemic chemotherapy. The selection of pharmacothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniyal, Adhitiya, Santoso, Ivana, Gunawan, Nadira Hasna Putri, Barliana, Melisa Intan, Abdulah, Rizky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882715/
https://www.ncbi.nlm.nih.gov/pubmed/33603458
http://dx.doi.org/10.2147/BCTT.S284453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882715/
https://www.ncbi.nlm.nih.gov/pubmed/33603458
http://dx.doi.org/10.2147/BCTT.S284453

Ejemplares similares